Clinical trial
China Antihypertensive Trial in Acute Ischemic Stroke II
NCT03479554 is registered in ClinicalTrials.gov with Tulane University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- China Antihypertensive Trial in Acute Ischemic Stroke II
- Lead sponsor
- Tulane University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 13, 2018
- Completion date
- January 15, 2023
- Enrollment
- 4,810 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke